CME Group CEO Terry Duffy to Step Down in March 2027; Fitzpatrick Name

This summary was generated by AI from the company's SEC filing and may contain errors — always verify against the primary source on SEC.gov.

The short version

CME Group announced that CEO Terry Duffy will step down from the Chief Executive role on March 1, 2027, and transition to Executive Chairman. Lynne Fitzpatrick, the company's President and Chief Financial Officer, will become Chief Executive Officer and join the Board at that time. Duffy will remain with the company through the end of 2027 in his executive chairman role.

CME Group announced that Terry Duffy, who has led the company for more than 25 years, will step down as Chief Executive Officer on March 1, 2027, and move into the role of Executive Chairman. Lynne Fitzpatrick, currently President and Chief Financial Officer, will become Chief Executive Officer and join the company's Board of Directors at the same time.

Under a new agreement filed with the SEC, Duffy will continue in his Chief Executive role through the end of February 2027 (or the filing of the company's 2026 annual report, whichever is later). He will then serve as Executive Chairman through December 31, 2027, providing advisory services to the Board.

Duffy's Long Tenure

Duffy was appointed Chairman in 2002 and became Executive Chairman in 2006 before taking on the combined Chairman and Chief Executive role in 2016. During his time leading CME Group, the company grew from a Chicago-based trading institution into a global marketplace. The company traded an average daily volume of 28.1 million contracts last year and has a market value exceeding $95 billion—up more than 8,000% since Duffy took the company public in 2002.

Major milestones under Duffy's leadership include the 2007 merger with the Chicago Board of Trade, the 2008 acquisition of the New York Mercantile Exchange, navigating the 2008 financial crisis, and more recently the 2018 acquisition of NEX and a partnership with Google Cloud announced in 2021.

Compensation Details

Under the transition agreement, Duffy will receive a base salary of at least $2 million per year during the agreement term. He is also eligible for an annual performance bonus with a target opportunity of 200% of his base salary and a stock grant worth 600% of his base salary for 2027. All equity awards will vest fully during this period. The agreement also provides health insurance continuation for up to 48 months after his employment ends.

If Duffy is terminated without cause before the agreement ends, he would receive severance of two times his annual base salary, continuation of certain equity awards, and extended health coverage.

Key facts

Terry Duffy to step down as CEO effective March 1, 2027

Lynne Fitzpatrick to become Chief Executive Officer and join the Board on March 1, 2027

Duffy to transition to Executive Chairman through December 31, 2027

Duffy has led CME Group for more than 25 years (Chairman since 2002)

CME Group traded 28.1 million contracts daily on average in 2025

CME Group market capitalization exceeds $95 billion

Duffy's base salary: at least $2 million per year

Duffy's target bonus: 200% of base salary

Duffy's equity grant for 2027: 600% of base salary in fully vested shares

Agreement effective January 1, 2027, expires December 31, 2027

Form 8-K filed June 17, 2026

Why it matters

This marks a significant leadership transition at one of the world's largest financial exchanges after Duffy's 25-year run building CME Group into a global powerhouse. Investors will be watching whether Fitzpatrick can maintain the company's growth trajectory and operational execution. The structured transition, with Duffy remaining as Executive Chairman through year-end 2027, allows for a staged handoff of responsibilities. The filing also reveals the compensation structure for this period, including substantial equity grants and severance protections, which shareholders may scrutinize as part of the broader leadership succession.

Frequently asked

When will Terry Duffy step down as CEO?

Duffy will step down as Chief Executive Officer on March 1, 2027, or on the date CME Group files its 2026 annual report (Form 10-K), whichever is later.

Who is replacing Duffy as CEO?

Lynne Fitzpatrick, currently President and Chief Financial Officer, will become Chief Executive Officer and join the Board of Directors on March 1, 2027.

Will Duffy leave the company entirely?

No. Duffy will transition to Executive Chairman and remain with CME Group through December 31, 2027, providing advisory services to the Board.

How long has Duffy been leading CME Group?

Duffy has been at the helm of CME Group for more than 25 years, serving as Chairman since 2002 and as Chairman and Chief Executive Officer since 2016.

What the filing reported

5.02 Departure/Election of Directors or Officers

7.01 Regulation FD Disclosure

9.01 Financial Statements & Exhibits

CME Group CEO Terry Duffy to Step Down in March 2027; Fitzpatrick Named Successor